WhatsApp
Facebook
Instagram
X (Twitter)
YouTube
LinkedIn

24/7 Customer Support

kelinmei clindamycin phosphate injection 2ml 0

Description

 Indication & Scope

Clindamycin Phosphate Injection is a prescription lincosamide antibiotic indicated for the treatment of susceptible infections caused by Gram-positive aerobic bacteria and anaerobic bacteria, including respiratory tract infections, skin and soft tissue infections, bone and joint infections, septicemia, intra-abdominal infections, pelvic infections, and gynecologic infections. It is also an alternative for patients with penicillin allergy when appropriate.

  • Mechanism: Clindamycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, suppressing bacterial growth. At high concentrations, it may exhibit bactericidal activity against susceptible organisms.
  • Drug class: Lincosamide antibiotic.
  • Clinical use: Treatment of susceptible Gram-positive and anaerobic bacterial infections, including bone, skin, respiratory, intra-abdominal, and pelvic infections.
Specification
Generic Name Clindamycin Phosphate Injection
Brand Name KeLinMei®
Ingredient Clindamycin Phosphate
Dosage Form Injection
Package 2 ml : 0.3 g/vial, 4 vials/box
Conditions Treated Respiratory tract infections, skin and soft tissue infections, bone and joint infections, septicemia, intra-abdominal infections, pelvic infections, and other susceptible anaerobic or Gram-positive bacterial infections
Taboos Hypersensitivity to clindamycin, lincomycin, or any component of the formulation; history of antibiotic-associated colitis
Place of origin China
Prescription type Prescription Drug (Rx)
Storage Conditions Store below 20°C, protected from light. Do not freeze.
Manufacturer North China Pharmaceutical Co., Ltd.
Registration Authority National Medical Products Administration (NMPA), China
Approval Number H10940029
Approval Date October 22, 2024
Shelf Life 24 months

How to use ?

Recommended Dose: Adults: 600 mg–2.7 g daily by intramuscular injection or intravenous infusion in 2–4 divided doses depending on infection severity.

 

Time: Intravenous infusion should be administered slowly after dilution. Do not administer by rapid IV injection.

 

Instructions for use: Dilute before intravenous administration and use according to the approved prescribing information. Continue treatment for the full prescribed course.

 

Interaction: Avoid concomitant use with erythromycin because of antagonistic antibacterial activity. Use cautiously with neuromuscular blocking agents and warfarin.

 

Side effects: Common adverse reactions include injection-site pain, nausea, vomiting, diarrhea, abdominal pain, rash, elevated liver enzymes, and the risk of Clostridioides difficile-associated diarrhea or pseudomembranous colitis.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support

Certificate of Analysis

GMP Certificate

Commercial Invoice

Packing List & CPP

Cold Chain Logistics

Customs Documentation

Scientific and regulatory sources

1.WHO References
2.NMPA
3.FDA
4.EMA

FAQ

What infections is Clindamycin Phosphate Injection used for?

It is indicated for susceptible Gram-positive and anaerobic bacterial infections involving the respiratory tract, skin, bone, abdomen, pelvis, and bloodstream.

Can it be used in patients allergic to penicillin?

Yes. It is commonly used as an alternative antibiotic for appropriate infections in patients with penicillin allergy.

Can it treat Gram-negative bacterial infections?

No. Clindamycin has limited activity against aerobic Gram-negative bacteria and is not suitable as monotherapy for these infections.

What is the most important safety concern?

Persistent diarrhea during or after treatment may indicate Clostridioides difficile-associated colitis and requires immediate medical evaluation.

KeLinMei® | Clindamycin Phosphate | Bacterial Infections | DengYueRX

INN: Clindamycin Phosphate
Indications: Gram-positive and anaerobic bacterial infections
Dosage Form: Injection
Strength: 2 mL : 0.3 g/Vial

Original price was: $1.00.Current price is: $0.84.

Low MOQ

WHO-GMP

Worldwide Delivery

Compliance and Regulatory Documents

Related Products

Scroll to Top

Your Cart

Your Cart

Your Cart is Empty

Start Shopping
Continue Shopping
Payment Details
Sub Total $0.00